10577 Results

Congress Abstract

Comparison of therapy outcomes between 2-dimensional radiotherapy and IMRT for early glottic cancer

Authors:

Sandeep Purohit1, Parveen Ahlawat1, Munish Gairola1, Sarthak Tandon1, Muhammed Ismail Sharief1, Nishtha Sachdeva1, Tulika Singh1, Kiran Dobriyal1, Athira Krishnan1

1Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, Radiation Oncology, New Delhi, India

Show Affiliations

Congress Abstract

Efficacy and Toxicity of Proton therapy and Tomotherapy combination in sacral chordoma patients

Authors: Beddok|, Arnaud(1,2)*[Arnaud.beddok@curie.fr];Saint-Martin|, Caroline(3);Mammar|, Hamid(1,2);Goudjil|, Farid(2);Zefkili|, Sofia(1);Helfre|, Sylvie(1,2);Feuvret|, Loïc(2,4);Bolle|, Stéphanie(2,5);Froelich|, Sebastien(6);Amessis|, Malika(1);Peurien|, Dominique(1);Dendale|, Rémi(1,2);Alapetite|, Claire(1,2);Calugaru|, Valentin(1,2);
(1)Curie Institute, Radiation Oncology, Paris, France;(2)Curie Institute, Department of Proton therapy, Orsay, France;(3)Curie Institute, Department of statistics, Saint Cloud, France;(4)Pitié-Salpêtrière Hospital, Radiation Oncology, Paris, France;(5)Gustave Roussy Institute, Radiation Oncology, Villejuif, France;(6)Lariboisière Hospital, Neurosurgery, Paris, France;
Show Affiliations

Congress Abstract

Validation of optical surface/thermal imaging and X-ray positioning accuracy for SRS treatments

Authors:

Vanessa da Silva Mendes1, Michael Reiner1, Stefanie Corradini1, Maximilian Niyazi1, Claus Belka1, Guillaume Landry1, Philipp Freislederer1

1University Hospital, LMU Munich, Department of Radiation Oncology, Munich, Germany

Show Affiliations

Journal Article

Stereotactic radiosurgery (SRS) – A new normal for small cell lung cancer?

Authors: Ian Pereira, Ben Slotman, Chad G. Rusthoven, Matthew S. Katz, Richard Simcock, Hina Saeed

Congress Abstract

Harms and Quality of Life Results of the Dose Escalated Chemoradiation Arm in CompARE phase III RCT

Authors:

Margriet Vreugdenhil1, Piers Gaunt2, Wenyu Liu2, Charlotte Firth2, Isla Humphreys2, Paul Sanghera3, Andrew Hartley3, Mehmet Sen4, Anthony Kong5, Devraj Srinivasan6, Rafael Moleron7, Konstantinos Geropantas8, Andrew Chan9, Lorcan O'Toole10, Hoda Booz11, Jim Lester12, Bernadette Foran12, Charles Fong13, Tom Roques8, Rita Simoes14, Zohal Nabi14, Hisham Mehanna15

1University Hospitals Birmingham NHS Foundation Trust, Oncology, Birmingham, United Kingdom; 2Institute of Cancer and Genomic Sciences, University of Birmingham, Cancer Research Clinical Trials Unit, Birmingham, United Kingdom; 3University Hospitals Birmingham NHS Trust, Oncology, Birmingham, United Kingdom; 4St. James's Institute of Oncology, Clinical Oncology, Leeds, United Kingdom; 5Kings College London, Comprehensive Cancer Centre, London, United Kingdom; 6Edinburgh Cancer Centre, Clinical Oncology, Edinburgh , United Kingdom; 7Aberdeen Royal Infirmary, Clinical Oncology, Aberdeen, United Kingdom; 8Norfolk & Norwich University Hospitals NHS FT, Clinical Oncology, Norwich, United Kingdom; 9University Hospitals Coventry and Warwickshire, Arden Cancer Centre, Coventry, United Kingdom; 10Queen’s Centre for Oncology, Clinical Oncology, Cottingham, Hull, United Kingdom; 11University Hospitals Bristol NHS Foundation Trust, Oncology, Bristol, United Kingdom; 12Weston Park Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Clinical Oncology, Sheffield, United Kingdom; 13University Hospitals Birmingham NHS Trust, Oncology, Birmingham , United Kingdom; 14National Radiotherapy Trials Quality Assurance Group (RTTQA), Radiotherapy Physics, Mount Vernon Cancer Centre, Middlesex, United Kingdom; 15Institute of Cancer and Genomic Sciences, University of Birmingham, Institute of Head and Neck Studies and Education, Birmingham, United Kingdom

Show Affiliations

Congress Abstract

Total body irradiation practice in Australia and New Zealand: Results of a Survey

Authors: Fog|, Lotte(1)*[lotte.fog@petermac.org];Wirth|, Andrew(2);MacManus|, Michael(3);Downes|, Simon(4);Grace|, Michael(5);Moggre|, Alicia(6);Mugabe|, Koki(7);Neveri|, Gabor(8);Nourbehesht|, Lisa(9);Panetieri|, Vanessa(10);Pope|, Dane(11);Sim|, Lucy(12);Stanton|, Cameron(13);Steer|, Blair(14);Stewart|, Alan(15);Ungureanu|, Elena(1);Kron|, Tomas(1);
(1)The Peter MacCallum Cancer Centre, Medical Physics, Melbourne, Australia;(2)Peter MacCallum Cancer Centre, Radiation Oncology, Melbourne, Australia;(3)The Peter MacCallum Cancer Centre, Radiation Oncology, Melbourne, Australia;(4)Prince of Wales Hospital, Medical Physics, Randwick, Australia;(5)St. Vincents Hospital, Medical Physics, Darlinghurst, Australia;(6)Christchurch Hospital, Medical Physics, Christchurch, New Zealand;(7)Waikato Hospital, Medical Physics, Hamilton, New Zealand;(8)Sir Charles Gairdner Hospital, Medical physics, Nedlands, Australia;(9)Crown Princess Mary Cancer Centre Westmead, Medical physics, Westmead, Australia;(10)Alfred Health Radiation Oncology- The Alfred Hospital, Medical physics, Melbourne, Australia;(11)Chris O’Brien Lifehouse, Medical physics, Camperdown, Australia;(12)Radiation Oncology Princess Alexandra Raymond Terrace, Medical physics, South Brisbane, Australia;(13)Royal North Shore Hospital, Medical physics, St. Leonards, Australia;(14)Wellington Regional Hospital, Medical physics, Wellington, New Zealand;(15)Auckland City Hospital, Medical physics, Auckland, New Zealand;
Show Affiliations

Congress Abstract

A stereoscopic CT artifact reduction method image quality comparison to current vendor solutions

Authors: Branco|, Daniela(1)*[dbranco@mdanderson.org];Kry|, Stephen(1);Paige|, Taylor(1);Rong|, John(2);Zhang|, Xiaodong(1);Frank|, Steven(3);Followill|, David(1);
(1)MD Anderson Cancer Center, Radiation Physics, HOUSTON, USA;(2)MD Anderson Cancer Center, Imaging Physics, Houston, USA;(3)MD Anderson Cancer Center, Radiation Oncology, Houston, USA;
Show Affiliations

Webcast

What is the target volume?

Authors: Florence Huguet

Congress Abstract

The development of a decision aid for operable oropharyngeal carcinoma in the Netherlands

Authors:

Anne Heirman1, Lisette Van der Molen1, Richard Dirven1, Michiel Van den Brekel2

1NKI-AvL, Head and Neck Oncology and Surgery, Amsterdam, The Netherlands; 2NKI-AvL, Head and Neck Oncoloy and Surgery, Amsterdam, The Netherlands

Show Affiliations
*:*